Affimed NV (AFMD)
5.31
-0.13
(-2.39%)
USD |
NASDAQ |
May 17, 16:00
5.31
0.00 (0.00%)
After-Hours: 19:10
Affimed Enterprise Value: 15.69M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 15.69M |
| May 15, 2024 | 14.17M |
| May 14, 2024 | 12.64M |
| May 13, 2024 | 12.95M |
| May 10, 2024 | 12.80M |
| May 09, 2024 | 12.57M |
| May 08, 2024 | 12.49M |
| May 07, 2024 | 12.49M |
| May 06, 2024 | 16.45M |
| May 03, 2024 | 15.38M |
| May 02, 2024 | 13.56M |
| May 01, 2024 | 14.01M |
| April 30, 2024 | 14.32M |
| April 29, 2024 | 16.45M |
| April 26, 2024 | 9.446M |
| April 25, 2024 | 7.162M |
| April 24, 2024 | 7.162M |
| April 23, 2024 | 14.32M |
| April 22, 2024 | 8.989M |
| April 19, 2024 | 11.27M |
| April 18, 2024 | 10.05M |
| April 17, 2024 | 12.49M |
| April 16, 2024 | 14.62M |
| April 15, 2024 | 16.45M |
| April 12, 2024 | 20.41M |
| Date | Value |
|---|---|
| April 11, 2024 | 22.85M |
| April 10, 2024 | 21.63M |
| April 09, 2024 | 25.74M |
| April 08, 2024 | 29.24M |
| April 05, 2024 | 31.53M |
| April 04, 2024 | 32.59M |
| April 03, 2024 | 34.27M |
| April 02, 2024 | 30.92M |
| April 01, 2024 | 29.55M |
| March 28, 2024 | 13.56M |
| March 27, 2024 | 14.01M |
| March 26, 2024 | 13.86M |
| March 25, 2024 | 11.88M |
| March 22, 2024 | 8.837M |
| March 21, 2024 | 9.598M |
| March 20, 2024 | 13.40M |
| March 19, 2024 | 10.51M |
| March 18, 2024 | 1.984M |
| March 15, 2024 | 2.441M |
| March 14, 2024 | -1.440M |
| March 13, 2024 | 4.385M |
| March 12, 2024 | 11.85M |
| March 11, 2024 | 13.20M |
| March 08, 2024 | 24.03M |
| March 07, 2024 | 20.17M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-86.47M
Minimum
Mar 24 2023
1.086B
Maximum
Apr 28 2021
209.06M
Average
110.41M
Median
Dec 02 2019
Enterprise Value Benchmarks
| InflaRx NV | -5.240M |
| MorphoSys AG | 2.852B |
| BioNTech SE | 5.744B |
| Immatics NV | 505.00M |
| CureVac NV | 332.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.76M |
| Revenue (Quarterly) | 0.4448M |
| Total Expenses (Quarterly) | 26.50M |
| EPS Diluted (Quarterly) | -1.497 |
| Profit Margin (Quarterly) | -4.89K% |
| Earnings Yield | -144.5% |
| Normalized Earnings Yield | -146.65 |